Department of Neurology, Baylor Scott and White Health, Temple, TX, USA.
Department of Neurology, University of Texas Dell Medical School, University of Texas, Austin, TX, USA.
J Clin Exp Neuropsychol. 2021 Nov;43(9):918-925. doi: 10.1080/13803395.2022.2034753. Epub 2022 Feb 9.
The Uniform Data Set 3.0 neuropsychological battery (UDS3NB) is well developed for research with Alzheimer's disease and related dementias, and may serve as a common set of measures of cognitive decline across neurodegenerative diseases. However, the battery has not been formally assessed in persons with Parkinson's disease (PD). The current research provides initial information on the convergent and ecological validity of the UDS3NB in individuals with PD.
Participants included 75 individuals diagnosed with PD from the Arizona Study of Aging and Neurodegenerative Disorders. Clinical dementia ratings, administered independently from the cognitive measures, identified individuals as having normal cognition ( = 38), Mild Cognitive Impairment (MCI; = 25) and dementia ( = 12). UDS3NB measures were compared between these groups, and correlations between UDS3NB measures, gold standard neuropsychological measures, and informant rated activities of daily living ability (ADL) were evaluated.
At the group-level, UDS3NB scores followed the expected pattern with higher scores in participants with PD but no cognitive diagnosis and lower in those with dementia; scores in the MCI group were between these extremes. Convergent validity was suggested by moderate correlations between UDS specific measures (i.e., Craft story) and measures such as the RAVLT. Ecological validity was suggested by statistically significant correlations between UDS3NB performance and caregiver ratings of ADLs, with speed and executive functioning measures (Trailmaking A; = -.51, < .01; Trailmaking B; = -.51, < .01) most strongly related to reported daily functioning.
Findings provide initial support for the convergent and ecological validity of the UDS3NB in individuals with PD. Implications and future directions for this battery are discussed.
统一数据集 3.0 神经心理学测试(UDS3NB)是为阿尔茨海默病和相关痴呆症的研究而开发的,并且可以作为跨神经退行性疾病认知能力下降的一组常见测试。然而,该测试尚未在帕金森病(PD)患者中进行正式评估。当前的研究为 PD 患者 UDS3NB 的收敛和生态有效性提供了初步信息。
参与者包括来自亚利桑那州衰老和神经退行性疾病研究的 75 名被诊断为 PD 的个体。认知测试独立于临床痴呆评估,将参与者分为认知正常(=38 人)、轻度认知障碍(MCI;=25 人)和痴呆(=12 人)。在这些组之间比较了 UDS3NB 测试的结果,并评估了 UDS3NB 测试与金标准神经心理学测试以及知情者评定的日常生活活动能力(ADL)之间的相关性。
在组水平上,UDS3NB 分数遵循预期模式,PD 患者但无认知诊断的分数较高,痴呆患者的分数较低;MCI 组的分数处于这两个极端之间。UDS 特定测试(即 Craft 故事)与 RAVLT 等测试之间的中等相关性表明了收敛效度。UDS3NB 表现与照顾者对 ADL 的评分之间具有统计学意义的相关性表明了生态效度,速度和执行功能测试(Trailmaking A;=-.51,<.01;Trailmaking B;=-.51,<.01)与报告的日常功能相关性最强。
研究结果初步支持 PD 患者 UDS3NB 的收敛和生态有效性。讨论了该测试对该领域的影响和未来方向。